Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2016 / Article

Corrigendum | Open Access

Volume 2016 |Article ID 2467420 | 1 page | https://doi.org/10.1155/2016/2467420

Corrigendum to “Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes”

Received28 Dec 2015
Accepted21 Jun 2016
Published09 Aug 2016

The authors would like to indicate that there has been an inadvertent error in “Stevioside from Stevia rebaudiana Bertoni Increases Insulin Sensitivity in 3T3-L1 Adipocytes” [1].

The Western blot image of Figure  6 that was uploaded for the -actin protein bands is incorrect. The corrected image of the -actin protein for Figure  6 is hereby attached. This error does not alter or affect the discussions and conclusions that have been reached in this paper.

Also in Figure  6, the pIRS1 bands were rearranged to match the pY20 group, because the blots were run in a different order.


  1. N. H. Mohd-Radzman, W. I. W. Ismail, S. S. Jaapar, Z. Adam, and A. Adam, “Stevioside from Stevia rebaudiana Bertoni increases insulin sensitivity in 3T3-L1 adipocytes,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 938081, 8 pages, 2013. View at: Publisher Site | Google Scholar

Copyright © 2016 Nabilatul Hani Mohd-Radzman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

644 Views | 347 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.